Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation

Differentiation therapies with all-trans retinoic acid (ATRA) have been successful in treating acute promyelocytic leukemia, a rare subtype of acute myeloid leukemia (AML). However, their efficacy is limited in the case of other AML subtypes. Here, we show that the combination of ATRA with salt-indu...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology 2021-02, Vol.113 (2), p.254-262
Main Authors: Zhang, Xue-Wen, Shen, Xing, Long, Wen-Yue, Xiao, He, Li, Feng-Jun, Xing, Shuang, Xiong, Guo-Lin, Yu, Zu-Yin, Cong, Yu-Wen
Format: Article
Language:English
Subjects:
Acute myeloid leukemia
Acute promyeloid leukemia
AKT protein
Cell cycle
Cell differentiation
Differentiation
Growth inhibition
Hematology
Inhibition
Kinases
Leukemia
MAP kinase
Medicine
Medicine & Public Health
Myeloid leukemia
Oncology
Original Article
Promyeloid leukemia
Retinoic acid
Salt-inducible kinase
Signal transduction
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Differentiation therapies with all-trans retinoic acid (ATRA) have been successful in treating acute promyelocytic leukemia, a rare subtype of acute myeloid leukemia (AML). However, their efficacy is limited in the case of other AML subtypes. Here, we show that the combination of ATRA with salt-inducible kinase (SIK) inhibition significantly enhances ATRA-mediated AML differentiation. SIK inhibition augmented the ability of ATRA to induce growth inhibition and G1 cell cycle arrest of AML cells. Moreover, combining ATRA and SIK inhibition synergistically activated the Akt signaling pathway but not the MAPK pathway. Pharmacological blockade of Akt activity suppressed the combination-induced differentiation, indicating an essential role for Akt in the action of the combination treatment. Taken together, our study reveals a novel role for SIK in the regulation of ATRA-mediated AML differentiation, implicating the combination of ATRA and SIK inhibition as a promising approach for future differentiation therapy.
ISSN:0925-5710
1865-3774
DOI:10.1007/s12185-020-03026-1